Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€79.35

€79.35

-0.980%
-0.78
-0.980%
€92.55
 
18.09.24 / Tradegate WKN: A14M2J / Symbol: MDT / Name: Medtronic / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Medtronic plc Stock

Medtronic plc shows a slight decrease today, losing -€0.780 (-0.980%) compared to yesterday.
We see a rather positive sentiment for Medtronic plc with 7 Buy predictions and 1 Sell predictions.
With a target price of 92 € there is a slightly positive potential of 15.94% for Medtronic plc compared to the current price of 79.35 €.
Our community identified positive and negative aspects for Medtronic plc stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Medtronic plc stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of Medtronic plc in the next few years

Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Medtronic plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Medtronic plc -0.980% -3.184% 3.388% 2.440% 6.140% -28.223% -20.650%
Dexcom Inc. 1.240% 0.660% -7.649% -29.864% -44.141% -47.862% 75.822%
Dentsply Sirona Inc. 1.410% 7.175% 3.933% -27.691% -25.264% -53.927% -46.774%
Zimmer Holdings 0.060% 1.153% -3.605% -15.464% -12.236% -22.302% -25.105%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-19

Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.

Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.

Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.

Comments

Prediction Buy
Perf. (%) -0.84%
Target price 94.500
Change
Ends at 22.08.25

Medtronic plc (NYSE: MDT) had its price target raised by analysts at Barclays PLC from $104.00 to $105.00. They now have an "overweight" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 2.49%
Target price 95.273
Change
Ends at 21.08.25

Medtronic plc (NYSE: MDT) had its price target raised by analysts at Wells Fargo & Company from $105.00 to $106.00. They now have an "overweight" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 5.61%
Target price 96.779
Change
Ends at 24.05.25

Medtronic plc (NYSE: MDT) had its price target raised by analysts at Wells Fargo & Company from $102.00 to $105.00. They now have an "overweight" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

News

3 Reasons Medtronic's Stock Can Continue Rallying Higher: https://g.foolcdn.com/editorial/images/789968/a-patient-undergoing-a-checkup-at-a-doctors-office.jpg
3 Reasons Medtronic's Stock Can Continue Rallying Higher

Medtronic (NYSE: MDT) hasn't been a terribly hot stock to own in recent years. Since 2021, its shares have declined by more than 20%. But recently, investors do appear to have been giving the stock

Medtronic Stock: Growth On Rise of the Cardiovascular Machines: https://www.marketbeat.com/logos/articles/med_20240908183338_chartw-mdt.jpg
Medtronic Stock: Growth On Rise of the Cardiovascular Machines

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases an aging population

Billionaire Ray Dalio's Former Hedge Fund Is Buying These 3 Top Dividend Stocks. Should You?: https://g.foolcdn.com/editorial/images/789676/growth.jpg
Billionaire Ray Dalio's Former Hedge Fund Is Buying These 3 Top Dividend Stocks. Should You?

Savvy investors often look to billionaire portfolios for quality dividend stock ideas. Ray Dalio, founder of Bridgewater Associates, has a stellar reputation for spotting promising investments